S&P 500   5,011.12 (-0.22%)
DOW   37,775.38 (+0.06%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
S&P 500   5,011.12 (-0.22%)
DOW   37,775.38 (+0.06%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
S&P 500   5,011.12 (-0.22%)
DOW   37,775.38 (+0.06%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)
S&P 500   5,011.12 (-0.22%)
DOW   37,775.38 (+0.06%)
QQQ   423.41 (-0.57%)
AAPL   167.04 (-0.57%)
MSFT   404.27 (-1.84%)
META   501.80 (+1.54%)
GOOGL   156.01 (+0.35%)
AMZN   179.22 (-1.14%)
TSLA   149.93 (-3.55%)
NVDA   846.71 (+0.76%)
AMD   155.08 (+0.69%)
NIO   4.00 (+2.30%)
BABA   68.88 (+0.09%)
T   16.33 (+1.30%)
F   12.06 (+0.17%)
MU   111.93 (-3.78%)
GE   152.94 (-1.75%)
CGC   7.83 (+20.65%)
DIS   112.43 (-0.45%)
AMC   2.92 (-2.01%)
PFE   25.39 (-0.12%)
PYPL   62.10 (-1.83%)
XOM   118.52 (-0.09%)

Avinger (AVGR) Competitors

$3.92
+0.25 (+6.81%)
(As of 04:34 PM ET)

AVGR vs. TMDIF, GMVDF, VERO, UTRS, AFIB, STSS, NURO, GBS, IONM, and VVOS

Should you be buying Avinger stock or one of its competitors? The main competitors of Avinger include Titan Medical (TMDIF), G Medical Innovations (GMVDF), Venus Concept (VERO), Minerva Surgical (UTRS), Acutus Medical (AFIB), Sharps Technology (STSS), NeuroMetrix (NURO), GBS (GBS), Assure (IONM), and Vivos Therapeutics (VVOS). These companies are all part of the "surgical & medical instruments" industry.

Avinger vs.

Avinger (NASDAQ:AVGR) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, community ranking, earnings, institutional ownership, risk and profitability.

18.3% of Avinger shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 4.3% of Avinger shares are owned by company insiders. Comparatively, 0.0% of Titan Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Avinger presently has a consensus price target of $5.00, indicating a potential upside of 28.21%. Given Avinger's higher probable upside, equities analysts plainly believe Avinger is more favorable than Titan Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avinger
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Titan Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Avinger has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.21, meaning that its stock price is 21% more volatile than the S&P 500.

In the previous week, Avinger had 2 more articles in the media than Titan Medical. MarketBeat recorded 2 mentions for Avinger and 0 mentions for Titan Medical. Avinger's average media sentiment score of 0.33 beat Titan Medical's score of 0.00 indicating that Avinger is being referred to more favorably in the media.

Company Overall Sentiment
Avinger Neutral
Titan Medical Neutral

Avinger received 393 more outperform votes than Titan Medical when rated by MarketBeat users.

CompanyUnderperformOutperform
AvingerOutperform Votes
393
59.91%
Underperform Votes
263
40.09%
Titan MedicalN/AN/A

Titan Medical has higher revenue and earnings than Avinger. Avinger is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avinger$7.65M0.81-$18.32M-$26.34-0.15
Titan Medical$17.63M0.26$6.95M$0.041.02

Titan Medical has a net margin of 0.00% compared to Avinger's net margin of -239.41%. Titan Medical's return on equity of 203.36% beat Avinger's return on equity.

Company Net Margins Return on Equity Return on Assets
Avinger-239.41% N/A -106.16%
Titan Medical N/A 203.36%73.09%

Summary

Avinger beats Titan Medical on 9 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVGR vs. The Competition

MetricAvingerSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$6.23M$3.63B$4.74B$7.44B
Dividend YieldN/A2.32%2.98%4.00%
P/E Ratio-0.1514.66230.6117.32
Price / Sales0.8158.432,315.0283.13
Price / CashN/A33.7646.9235.12
Price / Book-0.874.314.584.19
Net Income-$18.32M$6.52M$103.98M$214.01M
7 Day Performance-7.11%-4.52%-5.36%-4.88%
1 Month Performance35.17%-6.66%-4.96%-3.48%
1 Year Performance-58.52%13.93%8.28%3.81%

Avinger Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TMDIF
Titan Medical
0 of 5 stars
$0.05
flat
N/A-71.9%$5.70M$17.63M1.2533Gap Up
GMVDF
G Medical Innovations
0 of 5 stars
$0.02
flat
N/AN/A$5.20M$4.42M0.0084
VERO
Venus Concept
0 of 5 stars
$0.81
+32.7%
N/A-72.8%$5.16M$76.35M-0.12384Gap Up
UTRS
Minerva Surgical
0 of 5 stars
$0.56
flat
$20.00
+3,471.4%
-89.8%$4.97M$50.29M-0.07174News Coverage
Gap Down
AFIB
Acutus Medical
0 of 5 stars
$0.17
flat
N/A-76.4%$4.92M$7.16M-0.13225News Coverage
STSS
Sharps Technology
0.492 of 5 stars
$0.31
-3.1%
N/A-73.1%$4.89MN/A0.0057News Coverage
Gap Down
NURO
NeuroMetrix
0 of 5 stars
$3.51
-0.3%
N/A-69.0%$6.99M$5.90M-0.5626Analyst Report
News Coverage
GBS
GBS
0 of 5 stars
$2.94
-9.8%
N/A+521.3%$7.05M$440,000.00-5.257
IONM
Assure
0.8989 of 5 stars
$0.65
flat
$4.00
+516.3%
-79.4%$4.36M$10.98M0.00127Positive News
VVOS
Vivos Therapeutics
0 of 5 stars
$2.70
-2.5%
N/A-68.9%$7.37M$13.80M-0.24154Positive News

Related Companies and Tools

This page (NASDAQ:AVGR) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners